Tempmate GmbH and PAXAFE have entered into a strategic partnership aimed at raising the standard of pharmaceutical supply chain monitoring, bringing together field-level operational monitoring and advanced digital analytics in a single integrated approach.
Tempmate, founded in 1983, has grown from a specialist in temperature measurement into a global provider of monitoring solutions for sensitive goods. The company now serves more than 1,500 customers across 90 countries, processes over one million shipments annually and relies on a network of more than 100 distributors.
That evolution has culminated in chaingr®, tempmate’s flagship solution suite, which combines smart monitoring devices, cloud-based intelligence and expert services designed to reduce losses, maintain quality and support compliance across critical supply chains.
PAXAFE brings to the partnership a pharmaceutical logistics intelligence platform purpose-built for GDP- and GMP-regulated environments. Its offering focuses on lane planning, real-time visibility, quality operations and predictive analytics, with the objective of turning complex logistics data into actionable intelligence that reduces risk, protects compliance and ultimately supports patient outcomes.
Tempmate chief executive Andreas Stoll said the partnership represents the logical next step for a company that has spent more than 40 years building trust shipment by shipment. He said the alliance gives the pharmaceutical industry something it has long needed: the dependability of hard-earned operational experience combined with the power of advanced innovation in one integrated solution.
Together, the two companies say they now cover the full spectrum of pharmaceutical monitoring needs, from the capture and transmission of environmental data in the field to intelligent analysis, alerts and compliance reporting for regulated industries. The partnership also strengthens both companies’ capabilities in GDP- and GMP-regulated environments.
PAXAFE chief executive Ilya Preston said trust in pharmaceutical logistics is built over time through reliable execution and a relentless focus on outcomes. He described the collaboration not as a standard vendor relationship, but as a shared commitment to redefining what integrated pharmaceutical supply chain monitoring should deliver.
The partnership is built around several complementary strengths. These include more than 40 years of cold chain monitoring experience combined with the agility of a modern logistics intelligence platform; shared expertise across GDP, GMP, ISO 9001 and EcoVadis-recognised sustainability frameworks; a combined footprint in 90 countries; end-to-end transparency from monitoring devices to cloud dashboards and AI-powered analytics; and a patient-first focus centred on protecting the quality and efficacy of pharmaceutical products.
